2013 American Transplant Congress
Trends in Transplant Patient Safety Situation Reporting
Drexel Univ; UNOS; Lifelink of FL; Brigham & Women's Hosp
Background: The OPTN Operations & Safety Committee is charged with reviewing aggregated, de-identified safety situation data reported through the Improving Patient Safety (IPS) portal in…2013 American Transplant Congress
Inflammatory Milieu in (d-AIH) Reduces Regulatory T-Cell Function, The
Pediatrics, Lurie Children's Hospital, Chicago, IL; Pathology, Children's Hospital, Los Angeles, CA
Background: The mechanisms leading to de novo autoimmune hepatitis (d-AIH) remain unclear. Regulatory T cells (T-regs) can be induced to differentiate into inflammation associated Th17…2013 American Transplant Congress
Improvements in Living Versus Cadaveric Donor Intestinal Transplantation for Intestinal Failure: The Japanese Experience
Introduction: Parenteral nutrition (PN)-dependent patients still have numerous complications. Intestinal transplantation can significantly improve their prognosis and quality of life. We report on improvements in…2013 American Transplant Congress
Comparative Study of Adverse Events and Lymphocyte Recovery in Living Kidney Transplantation Patients Treated with/without Rituximab, a B Cell-Depleting Treatment
Urology, Tokyo Women's Medical University, Tokyo, Japan
Background: We have adopted a rituximab protocol for immunological high-risk recipients of living kidney transplantations, such as ABO-incompatible and HLA-incompatible kidney transplantations. As the number…2013 American Transplant Congress
Does Size Matter in Extended Criteria Donor (ECD) Kidney Transplantation?
The objective of the study was to determine if ECD kidney size has an impact on recipient 5-year patient and graft survival.A retrospective review of…2013 American Transplant Congress
Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation; a Single Center Experience for over 20 Years
Urology, Tokyo Women's Medical University, Tokyo, Japan
(Background) Although kidney transplantation is the most reassuring treatment for patients with end-stage renal disease (ESRD), shortage of organ donation in Japan is crucial. This…2013 American Transplant Congress
In Vitro Differentiation of Naïve/Memory B Cells into Plasma Cells: Difference in Mode of Drug Action between Mycophenolic Acid and Everolimus
INTRODUCTIONRecently, attention has been directed towards B cell immunity. However, B cell culture system has not been well established unlike T cell. We attempted to…2013 American Transplant Congress
Impact of Renal Replacement Therapy Following Adult Living Donor Liver Transplantation, The
Background: In deceased donor liver transplantation (DDLT) settings, the post-transplant acute renal failure with the induction of renal replacement therapy (RRT) had negative effects on…2013 American Transplant Congress
Prediction of Morbidity and Mortality in Living Donor Liver Transplant and Living Donor Kidney Transplant Patients by Using Immune Function Assays
Background: The ImmuKnow (IMK) assay is being considered as possible tool for identification of infection and rejection in transplant recipients. However, the predictive capability of…2013 American Transplant Congress
Protective Effect of Non-HLA IgG2 and Detrimental Effect of Non-HLA IgG1 & IgG3 Against Angiotensin II Type 1 Receptor (AT1R) in Kidney Transplantation
A longitudinal study on non-HLA antibodies (abs) showed a higher risk of graft failure (gf) in the presence of AT1R abs. The aim of the…
American Transplant Congress abstracts